PAMORELIN
Dead / Cancelled — Cancelled — Section 8 (as of 06 Apr 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85075562
- Registration number
- 4018126
- Mark type
- Stylized text
- Filed
- 01 Jul 2010
- Published for opposition
- 14 Jun 2011
- Registered
- 30 Aug 2011
- Attorney of record
- Duane M. Byers
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma, and polycystic ovarian cancer
Owner
- DEBIOPHARM S.A., LAUSANNE, CH
- DEBIOPHARM S.A., LAUSANNE, CH
- DEBIOPHARM S.A., LAUSANNE, CH
Prior registrations
Prosecution history
- 06 Apr 2018 — CANCELLED SEC. 8 (6-YR)
- 30 Aug 2011 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jun 2011 — PUBLISHED FOR OPPOSITION
- 12 May 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 May 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 May 2011 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 May 2011 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2011 — ASSIGNED TO LIE
- 18 Apr 2011 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Oct 2010 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Oct 2010 — NON-FINAL ACTION E-MAILED
- 18 Oct 2010 — NON-FINAL ACTION WRITTEN
- 13 Oct 2010 — ASSIGNED TO EXAMINER
- 06 Jul 2010 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED